This study examined the functional importance of EGFR and the molecular mechanisms regulating EGFR in tumor cluster formation, and then evaluated the therapeutic potential of the new anti-EGFR antibody LA1 in blocking metastasis of TNBC in vivo. Here, EGFR is linked to neoplasm.